Anyone discouraged by the continued absence of a prostate cancer screening programme, the difficulties in getting a clear ...

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...

Seven years after the activation of the prostate biopsy service using Fusion technology, one of the most advanced innovations ...

Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked No. 6 nationally for Urology by US News & World ...

St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC ...

Long NHS waiting lists are pushing more people to seek private scanning services, with MRI, ultrasound and CT scans available ...

By recognizing patterns in test results, AI can identify patients at risk of cancer, diabetes complications, heart disease ...

Scan.com is a British-based service offering access to private diagnostic imaging, including MRI, ultrasound and CT scans, ...

Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans is now offering histotripsy, a non ...

Histotripsy is a non-invasive treatment, approved by the Food and Drug Administration (FDA) in 2023, that uses ultrasound energy to destroy liver tumors in a single outpatient procedure. This includes ...

Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.

St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC programmeThe patients received Lutetium (177Lu) rhPSMA-10.1 Injections at ...